openPR Logo
Press release

Ascites Market to Expand Significantly by 2034, States DelveInsight Report | PharmaIN, AstraZeneca plc, Pfizer Inc., Novartis AG, Baxter International Inc., Becton, Dickinson and Company, Roche

03-31-2025 04:32 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Ascites Market to Expand Significantly by 2034, States

The Key Ascites Companies in the market include - PharmaIN, AstraZeneca plc, Pfizer Inc., Novartis AG, Baxter International Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Merit Medical Systems Inc., Neovii Pharmaceuticals AG, GI Supply, BioVie, Ocelot Bio, Movetis, Sanofi, Otsuka Beijing Research Institute, Grifols Therapeutics LLC, Norgine, and others.

DelveInsight's "Ascites Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Ascites, historical and forecasted epidemiology as well as the Ascites market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

To Know in detail about the Ascites market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Ascites Market Forecast [https://www.delveinsight.com/report-store/ascites-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Some of the key facts of the Ascites Market Report:

*
The Ascites market size is anticipated to grow with a significant CAGR during the study period (2020-2034)

*
In November 2024, Pharmanovia, an international pharmaceutical company specializing in commercializing innovative therapies and enhancing the lifecycle of established medicines, announced the expansion of its oncology portfolio through a new licensing agreement for catumaxomab, aimed at treating malignant ascites.

*
In 2023, the US ascites market size attributed to cirrhosis was valued at over USD 800 million, with projections indicating growth throughout the forecast period (2024-2034).

*
In 2023, the market size for diuretics used in the treatment of ascites caused by cirrhosis in the US was estimated to be approximately USD 140 million.

*
In 2023, the US had the highest number of ascites cases caused by cirrhosis among the 7MM, exceeding 152,000 cases. This figure is expected to rise throughout the forecast period (2024-2034).

*
In 2023, breast cancer contributed the highest number of ascites cases caused by malignancies in the US, with approximately 13,000 cases, followed by colorectal cancer.

*
In the US, severity-specific cases of Grade II and III ascites totaled approximately 125,000 in 2023.

*
Key Ascites Companies: PharmaIN, AstraZeneca plc, Pfizer Inc., Novartis AG, Baxter International Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Merit Medical Systems Inc., Neovii Pharmaceuticals AG, GI Supply, BioVie, Ocelot Bio, Movetis, Sanofi, Otsuka Beijing Research Institute, Grifols Therapeutics LLC, Norgine, and others

*
Key Ascites Therapies: PHIN-214, BIV201 (Terlipressin), OCE-205, catumaxomab, M0002, satavaptan (SR121463B), Tolvaptan, Albumin, Rifaximin, and others

*
The Ascites market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Ascites pipeline products will significantly revolutionize the Ascites market dynamics.

Ascites Overview

A surplus of intraperitoneal fluid is referred to as ascites (hydroperitoneum is a rare synonym). Ascites is a disorder where fluid builds up in the abdominal cavities. Ascites may be painful in extreme cases.

Get a Free sample for the Ascites Market Report

https://www.delveinsight.com/sample-request/ascites-market [https://www.delveinsight.com/sample-request/ascites-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Ascites Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Ascites Epidemiology Segmentation:

The Ascites market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:

*
Total Prevalence of Ascites

*
Prevalent Cases of Ascites by severity

*
Gender-specific Prevalence of Ascites

*
Diagnosed Cases of Episodic and Chronic Ascites

Download the report to understand which factors are driving Ascites epidemiology trends @ Ascites Epidemiology Forecast [https://www.delveinsight.com/sample-request/ascites-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Ascites Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Ascites market or expected to get launched during the study period. The analysis covers Ascites market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Ascites Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Ascites Therapies and Key Companies

*
PHIN-214: PharmaIN

*
BIV201 (Terlipressin): BioVie

*
OCE-205: Ocelot Bio

Discover more about therapies set to grab major Ascites market share @ Ascites Treatment Market [https://www.delveinsight.com/sample-request/ascites-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Ascites Market Strengths

*
The rise in the patient population of underlying conditions of ascites such as liver cirrhosis, alcoholism, kidney or heart failure, malignancy, etc. might contribute to an increase in the patient population of ascites

Ascites Market Opportunities

*
Limited approved, and emerging therapies in the pipeline offer a great opportunity for the investment and development of novel therapies

Scope of the Ascites Market Report

*
Study Period: 2020-2034

*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

*
Key Ascites Companies: PharmaIN, AstraZeneca plc, Pfizer Inc., Novartis AG, Baxter International Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Merit Medical Systems Inc., Neovii Pharmaceuticals AG, GI Supply, BioVie, Ocelot Bio, Movetis, Sanofi, Otsuka Beijing Research Institute, Grifols Therapeutics LLC, Norgine, and others

*
Key Ascites Therapies: PHIN-214, BIV201 (Terlipressin), OCE-205, catumaxomab, M0002, satavaptan (SR121463B), Tolvaptan, Albumin, Rifaximin, and others

*
Ascites Therapeutic Assessment: Ascites current marketed and Ascites emerging therapies

*
Ascites Market Dynamics: Ascites market drivers and Ascites market barriers

*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies

*
Ascites Unmet Needs, KOL's views, Analyst's views, Ascites Market Access and Reimbursement

To know more about Ascites companies working in the treatment market, visit @ Ascites Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/ascites-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Table of Contents

1. Ascites Market Report Introduction

2. Executive Summary for Ascites

3. SWOT analysis of Ascites

4. Ascites Patient Share (%) Overview at a Glance

5. Ascites Market Overview at a Glance

6. Ascites Disease Background and Overview

7. Ascites Epidemiology and Patient Population

8. Country-Specific Patient Population of Ascites

9. Ascites Current Treatment and Medical Practices

10. Ascites Unmet Needs

11. Ascites Emerging Therapies

12. Ascites Market Outlook

13. Country-Wise Ascites Market Analysis (2020-2034)

14. Ascites Market Access and Reimbursement of Therapies

15. Ascites Market Drivers

16. Ascites Market Barriers

17. Ascites Appendix

18. Ascites Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=ascites-market-to-expand-significantly-by-2034-states-delveinsight-report-pharmain-astrazeneca-plc-pfizer-inc-novartis-ag-baxter-international-inc-becton-dickinson-and-company-roche]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ascites Market to Expand Significantly by 2034, States DelveInsight Report | PharmaIN, AstraZeneca plc, Pfizer Inc., Novartis AG, Baxter International Inc., Becton, Dickinson and Company, Roche here

News-ID: 3947665 • Views:

More Releases from ABNewswire

Four Years Later, Therapist Burnout Remains the Leading Book on Clinician Burnout - As Research Confirms the Crisis Impacts Client Outcomes
Four Years Later, Therapist Burnout Remains the Leading Book on Clinician Burnou …
Four years after publication, Therapist Burnout remains a leading book addressing burnout among mental health clinicians. With over half of therapists reporting burnout and research linking clinician burnout to reduced client outcomes, the book reframes burnout as a systemic issue rather than a self-care failure, offering practical strategies for sustainable, ethical, and thriving clinical practice. Four years after its release, Therapist Burnout: Your Guide to Recovery and a Joyful, Sustainable Private
As AI Thermal Demands Surge, Rapidaccu Emerges as Key Player in Precision Liquid Cooling Component Manufacturing
As AI Thermal Demands Surge, Rapidaccu Emerges as Key Player in Precision Liquid …
With the global artificial intelligence sector aggressively scaling infrastructure to support Large Language Models (LLMs) and generative AI, thermal management has moved from a secondary concern to a critical engineering bottleneck. Amidst this shift, precision manufacturing specialist Rapidaccu has been identified as a notable enabler in the supply chain for high-performance cooling solutions, specifically for liquid cooling connectors and precision heat sinks. The rapid deployment of high-density GPU clusters has pushed
Walking as Children of Light in a Confused Generation
Walking as Children of Light in a Confused Generation
In To the Children of Light: Exposing Shadows, Restoring Truth, Pastor Thomas Reed Hammond Jr. calls believers back to full biblical obedience and Spirit-led conviction. Addressing doctrinal clarity, church leadership, discipline, and cultural compromise, the book urges Christians to move beyond superficial faith and walk as true children of light. Published by Kharis Publishing, it is available through major retailers. At a time when many believers quietly admit they are weary
New Book
New Book "Known" by Angela Guy is a Fresh Invitation to Know and Be Known by the …
In Known: Our God-Ordained Journey in the Wilderness, Angela Guy weaves her personal transformation story with the Israelites' journey through Exodus, inviting readers to move from self-reliance to surrender and deeper intimacy with God. Published by Kharis Publishing, this nonfiction release challenges believers to confront their "knowledge problem" and rediscover the God who calls them by name. What if the wilderness seasons of life are not evidence of God's absence, but

All 5 Releases


More Releases for Ascites

Ascites Epidemiology Forecast Report 2026-2035: Global Outlook
Why is ascites emerging as a growing global health challenge in patients with chronic liver disease and other systemic conditions? Understanding the Rising Importance of Ascites Epidemiology Ascites, the abnormal accumulation of fluid within the peritoneal cavity, represents one of the most serious and common complications of chronic liver disease, particularly cirrhosis. From a clinical and public health perspective, ascites is more than a symptom-it is a marker of disease progression, decompensation,
Ascites Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Ascites Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Ascites, historical and forecasted epidemiology as well as the Ascites market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Ascites market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Ascites market size from 2019 to 2032, segmented
Ascites Market Size, Share, Trends, Analysis and Forecast 2027
The Global Ascites Market is poised to register a CAGR of over 4% during the forecast period 2020 to 2027. Ascites are a condition in which excessive fluid accumulates in the abdominal cavity. Ascites are most commonly caused by liver cirrhosis. Portal hypertension is a sign of its presence. Ascites may also be caused by heart failure, kidney failure, cancer, and pancreatic infection. The malignant ascites associated with ovarian cancer play
Global Ascites Needle Market Analysis by 2020-2025
Global Info Research offers a latest published report on Ascites Needle Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Ascites Needle Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/Global-Ascites-Needle_p510224.html Market
Malignant Ascites Treatment Market: Competitive Dynamics & Global Outlook 2025
Market Research Report Store offers a latest published report on Malignant Ascites Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Malignant Ascites Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure
Global Ascites Market Healthcare Analysis 2018 to 2023
Global and Chinese  Ascites Industry, 2018 Market Research Report: The 'Global and Chinese  Ascites Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global  Ascites industry with a focus on the Chinese market. The report provides key statistics on the market status of the  Ascites manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.